Loading...

Expanding Health And Dairy Nutrition Will Unlock Global Demand

Published
02 Mar 25
Updated
05 Sep 25
AnalystConsensusTarget's Fair Value
€16.77
15.9% undervalued intrinsic discount
05 Sep
€14.10
Loading
1Y
-7.0%
7D
3.0%

Author's Valuation

€16.7715.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on05 Sep 25

Glanbia’s significantly lower future P/E multiple, despite stable revenue growth forecasts, suggests a more cautious outlook on valuation, though the consensus analyst price target remains unchanged at €16.77. What's in the News Glanbia will hold an Analyst/Investor Day to update on the Group's medium-term growth agenda.

Shared on01 May 25
Fair value Increased 0.49%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 3.47%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 1.41%

AnalystConsensusTarget has increased revenue growth from 3.5% to 4.0%.

Shared on02 Apr 25
Fair value Decreased 1.98%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 6.39%

AnalystConsensusTarget has decreased revenue growth from 4.6% to 3.8%.

Shared on19 Mar 25
Fair value Increased 2.89%

AnalystConsensusTarget has decreased shares outstanding growth rate from -0.0% to -0.0%.

Shared on12 Mar 25
Fair value Increased 6.39%

AnalystConsensusTarget has increased revenue growth from 3.9% to 4.6% and increased shares outstanding growth rate from -0.0% to -0.0%.